Allworth Financial LP Biotechnology

Allworth Financial LP

$20.2 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EYPT Eye Point Pharmaceuticals, Inc.	$366M	$0 0.0% of portfolio	93	Q2 2025 New
FATE Fate Therapeutics Inc	$91.2M	$0 0.0% of portfolio	4	Q4 2024 Reduced 90.24%
HRTX Heron Therapeutics, Inc.	$156M	$0 0.0% of portfolio	35	Q2 2025 New
HUMA Humacyte, Inc.	$185M	$0 0.0% of portfolio	357	Q2 2025 Added 78.5%
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	114	Q2 2025 New
ITOS I Teos Therapeutics, Inc.	$359M	$0 0.0% of portfolio	40	Q2 2025 New
JANX Janux Therapeutics, Inc.	$1.01B	$0 0.0% of portfolio	23	Q4 2024 Reduced 11.54%
KALV Kal Vista Pharmaceuticals, Inc.	$301M	$0 0.0% of portfolio	45	Q2 2025 Added 45.16%
LTRN Lantern Pharma Inc.	$48.2M	$0 0.0% of portfolio	100	Q1 2023 New
LQDA Liquidia Corp	$1.55B	$0 0.0% of portfolio	72	Q2 2025 Added 500.0%
MRVI Maravai Lifesciences Holdings, Inc.	$354M	$0 0.0% of portfolio	303	Q2 2025 Added 126.12%
MDXG Mimedx Group, Inc.	$821M	$0 0.0% of portfolio	43	Q2 2025 New
ORMP Oramed Pharmaceuticals Inc.	$81.5M	$0 0.0% of portfolio	300	Q2 2025 New
ORIC Oric Pharmaceuticals, Inc.	$377M	$0 0.0% of portfolio	2	Q2 2025 New
PGEN Precigen, Inc.	$375M	$0 0.0% of portfolio	294	Q2 2025 New
PBYI Puma Biotechnology, Inc.	$222M	$0 0.0% of portfolio	1	Q2 2025 New
RLYB Rallybio Corp	$16.1M	$0 0.0% of portfolio	50	Q2 2025 New
RGNX Regenxbio Inc.	$350M	$0 0.0% of portfolio	65	Q1 2025 New
ENOB Enochian Biosciences Inc	$244M	$0 0.0% of portfolio	122	Q2 2025 New
SGMO Sangamo Therapeutics, Inc	$81.4M	$0 0.0% of portfolio	1,000	Q2 2024 Reduced 33.2%
TNGX Tango Therapeutics, Inc.	$595M	$0 0.0% of portfolio	35	Q2 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.37B	$0 0.0% of portfolio	24	Q2 2025 New
TNYA Tenaya Therapeutics, Inc.	$31.4M	$0 0.0% of portfolio	531	Q2 2025 New
TYRA Tyra Biosciences, Inc.	$445M	$0 0.0% of portfolio	100	Q1 2025 New
URGN Uro Gen Pharma Ltd.	$437M	$0 0.0% of portfolio	13	Q2 2025 New
VALN Valneva Se	$650M	$0 0.0% of portfolio	7	Q1 2024 New
VTYX Ventyx Biosciences, Inc.	$149M	$0 0.0% of portfolio	250	Q2 2025 New
VRDN Viridian Therapeutics, Inc.\De	$717M	$0 0.0% of portfolio	33	Q1 2025 New
VOR Vor Biopharma Inc.	$63.2M	$0 0.0% of portfolio	60	Q2 2025 New
VYGR Voyager Therapeutics, Inc.	$131M	$0 0.0% of portfolio	11	Q1 2025 Reduced 78.43%
WVE Wave Life Sciences Ltd.	$734M	$0 0.0% of portfolio	124	Q2 2025 New
YMAB Y M Abs Therapeutics, Inc.	$372M	$0 0.0% of portfolio	201	Q2 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$80.3M	$0 0.0% of portfolio	42	Q2 2025 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	25	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.